View abstract

Cet abstract a été assigné à sessions
TitreThe IOP lowering effect of combined iStent +phacoemulcification in patients with glaucoma: prospective study
ButTo assess the IOP lowering effect of iStent insertion at the time of phacoemulsificationcombined in patients with glaucoma and to evaluate the number of topical medication needed to treat adequately the IOP, pre- and postoperatively.
MéthodesProspective study. The first 100 patients who underwent a combined operation were included in this study. The IOP was measured on preop, D1, W1, M1, M3, M6, M12 and further. The number of topical medication was calculated, based on number of different therapeutical molecules.
RésultatsThe follow-up period was between 3 to 18 months. The IOP preop was 25.06 mmHg and postoperatively was 16.8 mmHg after 6 months. A mean reduction in the number of glaucoma medications per patient was 1.3, following iStent implant with phacoemulsification.
ConclusionCombined iStent + Phacoemulcification is an micro invasive surgery of the high IOP in patients with glaucoma and can be used as a definite or temporary treatment for these patients.
Conflit d'intérêtNon
Auteur 1
NomHAAGDORENS
InitialesM
InstitutChirec Hospital Group, Delta site
VilleBrussels
Auteur 2
NomBOUSTANI
InitialesG
InstitutChirec Hospital Group, Delta site
VilleBrussels
Auteur 3
NomPOURJAVAN
InitialesS
InstitutChirec Hospital Group, Delta site
VilleBrussels
top ^